Suppr超能文献

更昔洛韦和膦甲酸钠治疗艾滋病相关巨细胞病毒多发性神经根病的疗效

Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy.

作者信息

Anders H J, Weiss N, Bogner J R, Goebel F D

机构信息

The Medical Policlinic, Ludwigs-Maximilian University, Munich, Germany.

出版信息

J Infect. 1998 Jan;36(1):29-33. doi: 10.1016/s0163-4453(98)92982-6.

Abstract

Cytomegalovirus (CMV) polyradiculopathy is a rare complication of AIDS in which ascending motor weakness, sensory loss and urinary retention are associated with polymorphonuclear pleocytosis and positive CMV polymerase chain reaction in the cerebrospinal fluid (CSF). We describe three patients with this syndrome. One patient's paresis improved after ganciclovir therapy. Another patient deteriorated despite foscarnet treatment, but improved after ganciclovir was added. The third patient died from ascending paralysis despite ganciclovir-foscarnet combination. Reviewing the literature, we conclude that antiviral treatment reduced mortality from 100 to 22%. In patients with ascending paralysis treatment, failure may be caused by viral drug resistance, at least in some patients. Risk factors for treatment failure are preceding monotherapy for other CMV diseases or persistent CSF pleocytosis on serial CSF analysis. We suggest that these patients should therefore be treated with the alternative drug or a ganciclovir-foscarnet combination therapy.

摘要

巨细胞病毒(CMV)多发性神经根病是艾滋病的一种罕见并发症,其特征为上行性运动无力、感觉丧失和尿潴留,同时伴有脑脊液(CSF)中多形核白细胞增多和CMV聚合酶链反应阳性。我们描述了三名患有该综合征的患者。一名患者在接受更昔洛韦治疗后轻瘫症状有所改善。另一名患者尽管接受了膦甲酸钠治疗,但病情仍恶化,在加用更昔洛韦后病情改善。第三名患者尽管接受了更昔洛韦 - 膦甲酸钠联合治疗,仍死于上行性麻痹。回顾文献,我们得出结论,抗病毒治疗使死亡率从100%降至22%。在患有上行性麻痹的患者中,治疗失败可能至少在某些患者中是由病毒耐药性引起的。治疗失败的危险因素是先前针对其他CMV疾病的单一疗法或连续脑脊液分析中持续的脑脊液多形核白细胞增多。因此,我们建议这些患者应接受替代药物治疗或更昔洛韦 - 膦甲酸钠联合治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验